Mark Rothera is Chief Commercial Officer at PTC THERAPEUTICS, INC. (PTCT). They have made 3 open-market trades across 2 companies since 2013, most recently 2023-12-01.
CIK 0001550424
3 open-market purchases totalling $436K since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIRX | BUY | 2023-11-30 | 2023-12-04 | $0.49 | $49K | +0.4% | +20.8% | +95.8% |
| PTCT | BUY | 2016-03-03 | 2016-03-07 | $6.23 | $12K | -11.1% | +12.0% | +33.0% |
| PTCT | SELL · 10b5-1 | 2015-03-17 | 2015-03-18 | $76.64 | $820K | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2015-03-13 | 2015-03-13 | $76.36 | $23K | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2015-02-23 | 2015-02-25 | $68.01 | $2.4M | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2015-01-20 | 2015-01-22 | $60.02 | $180K | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2015-01-16 | 2015-01-16 | $58.67 | $135K | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2015-01-13 | 2015-01-15 | $58.04 | $563K | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2014-09-24 | 2014-09-26 | $44.63 | $714K | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2014-09-15 | 2014-09-16 | $36.24 | $290K | -28.3% | -2.3% | -2.3% |
| PTCT | BUY | 2013-06-25 | 2013-06-27 | $15.00 | $375K | -28.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.